Publications by authors named "Fausto Rossini"

Claim this Profile
P
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Riccardo Bruna, Fabio Benedetti, Carola Boccomini, Caterina Patti, Anna Maria Barbui, Fausto Rossini

Haematologica· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
Davide Ippolito, Cammillo Talei Franzesi, Sara Spiga, Valeria Besostri, Sara Pezzati, Fausto Rossini

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implemented myeloma management with whole-body low-dose CT scan: a real life experience.
Silvia Mangiacavalli, Sara Pezzatti, Fausto Rossini, Elisa Doni, Federica Cocito

Leuk Lymphoma· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
Alessandra Tedeschi, Davide Rossi, Marina Motta, Giulia Quaresmini, Marianna Rossi, Fausto Rossini

Haematologica· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
Angelo Belotti, Elisa Doni, Silvia Bolis, Fausto Rossini, Ivana Casaroli

Clin Lymphoma Myeloma Leuk· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
Davide Ippolito, Valeria Besostri, Pietro Andrea Bonaffini, Fausto Rossini, Alessandro Di Lelio

Eur J Radiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.
Michael Mian, Andrés J M Ferreri, Andrea Rossi, Annarita Conconi, Richard Tsang, Fausto Rossini

Leuk Lymphoma· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adjusted ISS (RaISS) is a simple and reliable prognostic scoring system for predicting progression-free survival in transplanted patients with multiple myeloma.
Alessandro Corso, Monica Galli, Silvia Mangiacavalli, Fausto Rossini, Andrea Nozza

Am J Hematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study.
Michael Mian, Gianluca Gaidano, Annarita Conconi, Richard Tsang, Mary K Gospodarowicz, Fausto Rossini

Leuk Lymphoma· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.
Livio Pagano, Morena Caira, Anna Candoni, Massimo Offidani, Bruno Martino, Fausto Rossini

Haematologica· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
Antonio Palumbo, Francesca Gay, Patrizia Falco, Claudia Crippa, Vittorio Montefusco, Fausto Rossini

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of a pre-existing neuropathy on the course of bortezomib-induced peripheral neurotoxicity.
Francesca Lanzani, Laura Mattavelli, Barbara Frigeni, Fausto Rossini, Sara Cammarota

J Peripher Nerv Syst· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature.
Pellegrino Musto, Potito Rosario Scalzulli, Elisabetta Terruzzi, Fausto Rossini, Pasquale Iacopino

Leuk Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bortezomib in patients with plasma cell leukemia.
Pellegrino Musto, Fausto Rossini, Francesca Gay, Vincenzo Pitini, Tommasina Guglielmelli

Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.
Antonio Palumbo, Sara Bringhen, Tommaso Caravita, Emanuela Merla, Vincenzo Capparella, Fausto Rossini

Lancet· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.
Fausto Rossini, Elisabetta Terruzzi, Luisa Verga, Alessandra Larocca, Sara Marinoni

Support Care Cancer· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial.
Antonio Palumbo, Sara Bringhen, Maria Teresa Petrucci, Pellegrino Musto, Fausto Rossini

Blood· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Fausto Rossini, Elisabetta Terruzzi, Daniele Perego, Isabella Miccolis, Franca Rivolta

Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin.
PAOLO Lissoni, MARIO Mandala, FAUSTO Rossini, LUCA Fumagalli, SANDRO Barni

Hematology· January 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis